Literature DB >> 32016282

The role of type 1 interferons in coagulation induced by gram-negative bacteria.

Xinyu Yang1, Xiaoye Cheng1, Yiting Tang2, Xianhui Qiu1, Zhongtai Wang1, Guang Fu3, Jianfeng Wu4, Haixia Kang5, Jing Wang5, Haichao Wang6, Fangping Chen1, Xianzhong Xiao7,8, Timothy R Billiar9, Ben Lu1,7,8.   

Abstract

Bacterial infection not only stimulates innate immune responses but also activates coagulation cascades. Overactivation of the coagulation system in bacterial sepsis leads to disseminated intravascular coagulation (DIC), a life-threatening condition. However, the mechanisms by which bacterial infection activates the coagulation cascade are not fully understood. Here we show that type 1 interferons (IFNs), a widely expressed family of cytokines that orchestrate innate antiviral and antibacterial immunity, mediate bacterial infection-induced DIC by amplifying the release of high-mobility group box 1 (HMGB1) into the bloodstream. Inhibition of the expression of type 1 IFNs and disruption of their receptor IFN-α/βR or downstream effector (eg, HMGB1) uniformly decreased gram-negative bacteria-induced DIC. Mechanistically, extracellular HMGB1 markedly increased the procoagulant activity of tissue factor by promoting the externalization of phosphatidylserine to the outer cell surface, where phosphatidylserine assembles a complex of cofactor-proteases of the coagulation cascades. These findings not only provide novel insights into the link between innate immune responses and coagulation, but they also open a new avenue for developing novel therapeutic strategies to prevent DIC in sepsis.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32016282      PMCID: PMC7118812          DOI: 10.1182/blood.2019002282

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  68 in total

Review 1.  Disseminated intravascular coagulation.

Authors:  M Levi; H Ten Cate
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

2.  NF-κB Mediated Transcription in Human Monocytic Cells and Endothelial Cells.

Authors:  G C Parry; N Mackman
Journal:  Trends Cardiovasc Med       Date:  1998-04       Impact factor: 6.677

3.  CIRCULATING MICROPARTICLES, BLOOD CELLS, AND ENDOTHELIUM INDUCE PROCOAGULANT ACTIVITY IN SEPSIS THROUGH PHOSPHATIDYLSERINE EXPOSURE.

Authors:  Yan Zhang; Huan Meng; Ruishuang Ma; Zhangxiu He; Xiaoming Wu; Muhua Cao; Zhipeng Yao; Lu Zhao; Tao Li; Ruijuan Deng; Zengxiang Dong; Ye Tian; Yayan Bi; Junjie Kou; Hemant S Thatte; Jin Zhou; Jialan Shi
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

4.  Septic shock among patients with systemic lupus erythematosus: Short and long-term outcome. Analysis of a French nationwide database.

Authors:  Arthur Mageau; Karim Sacré; Anne Perozziello; Stéphane Ruckly; Claire Dupuis; Lila Bouadma; Thomas Papo; Jean-François Timsit
Journal:  J Infect       Date:  2019-04-08       Impact factor: 6.072

5.  Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo.

Authors:  Ralph Tiedt; Tibor Schomber; Hui Hao-Shen; Radek C Skoda
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

6.  JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation.

Authors:  Ben Lu; Daniel J Antoine; Kevin Kwan; Peter Lundbäck; Heidi Wähämaa; Hanna Schierbeck; Melissa Robinson; Marieke A D Van Zoelen; Huan Yang; Jianhua Li; Helena Erlandsson-Harris; Sangeeta S Chavan; Haichao Wang; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

7.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

8.  The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.

Authors:  Tiffany Horng; Gregory M Barton; Richard A Flavell; Ruslan Medzhitov
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

9.  A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.

Authors:  Bradley D Freeman; Barbara A Zehnbauer; Timothy G Buchman
Journal:  Shock       Date:  2003-07       Impact factor: 3.454

10.  Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature.

Authors:  Elzbieta Kolaczkowska; Craig N Jenne; Bas G J Surewaard; Ajitha Thanabalasuriar; Woo-Yong Lee; Maria-Jesus Sanz; Kerri Mowen; Ghislain Opdenakker; Paul Kubes
Journal:  Nat Commun       Date:  2015-03-26       Impact factor: 14.919

View more
  25 in total

1.  Type 1 interferon aggravates lipopolysaccharide-induced sepsis through upregulating Caspase-11 and Gasdermin D.

Authors:  Yan Wang; Xiaolei Zhang; Yujie Guo; Xiao Li; Guanyi Guo; Zhiyun Niu; Jingyu Zhang
Journal:  J Physiol Biochem       Date:  2021-01-30       Impact factor: 4.158

Review 2.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

Review 3.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 4.  Hyperinflammation, apoptosis, and organ damage.

Authors:  Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 5.  Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

Authors:  Ulf Andersson; William Ottestad; Kevin J Tracey
Journal:  Mol Med       Date:  2020-05-07       Impact factor: 6.354

Review 6.  Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.

Authors:  Sebastiano Cicco; Gerolamo Cicco; Vito Racanelli; Angelo Vacca
Journal:  Mediators Inflamm       Date:  2020-07-16       Impact factor: 4.711

7.  Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.

Authors:  Saravanan Subramaniam; Wolfram Ruf; Markus Bosmann
Journal:  Br J Pharmacol       Date:  2021-07-07       Impact factor: 8.739

Review 8.  Potential mechanisms of tumor progression associated with postoperative infectious complications.

Authors:  Hironori Tsujimoto; Minako Kobayashi; Hidekazu Sugasawa; Satoshi Ono; Yoji Kishi; Hideki Ueno
Journal:  Cancer Metastasis Rev       Date:  2021-01-03       Impact factor: 9.264

9.  An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling.

Authors:  Xiangyu Wang; Jian Shi; Zhaozheng Li; Ling Li; Rui Zhang; Yang Bai; Junmei Li; Fang Liang; Yiting Tang
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

Review 10.  Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury.

Authors:  Chao Deng; Lin Zhao; Zhi Yang; Jia-Jia Shang; Chang-Yu Wang; Ming-Zhi Shen; Shuai Jiang; Tian Li; Wen-Cheng Di; Ying Chen; He Li; Ye-Dong Cheng; Yang Yang
Journal:  Acta Pharmacol Sin       Date:  2021-05-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.